K-ras mutations in lung tumors from p53 mutant mice exposed to cigarette smoke

Ruisheng Yao, Yian Wang, Francesco D'Agostini, Alberto Izzotti, Ronald A. Lubet, Ming You, Silvio De Flora

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

In this study, we used p53 trangenic mice to investigate whether mice carrying this germline mutation would be susceptible to tobacco smoke-induced lung tumorigenesis. We subjected male transgenic mice and their wild-type littermates to whole-body exposure to environmental cigarette smoke (ECS) for up to 9.5 months. K-ras gene expression was significantly increased, 28 days after ECS exposure, in the apparently healthy lung of p53 mutant mice. An increase of lung tumor incidence and multiplicity was observed in p53 transgenic mice after exposure to ECS for either 5 months, followed by recovery in air for 4.5 months, or 9.5 continuative months of exposure. Conversely, no tumorigenic effect was observed in their wild-type littermates. Sequence analysis of the K-ras gene indicated that mutations had occurred at codon 12, 13 or codon 61 in tumors both from the air control group and tobacco smoke treatment groups. K-ras mutations were found in 100%, 100% and 77% of tumors from animals exposed to air, ECS for 5 months, followed by recovery in air for 4.5 months, and ECS for 9.5 continuative months, respectively. The K-ras mutations were seemingly not related to the p53 genotype of the animals or to ECS exposure. The mutation spectrum was similar in tumors from the different groups. An apparently higher incidence of K-ras codon 12 mutations in the 9.5-months ECS group was not statistically significant. These findings provide evidence that mice carrying a mutant p53 transgene appear to be more sensitive to ECS-induced lung tumors than the corresponding wild-type littermates. K-ras mutations seem to be independent of the p53 status but the early overexpression of this oncogene is related to the p53 status in ECS-exposed mice. These results suggest that tobacco smoke enhances lung tumorigensis primarily through promoting spontaneously occuring K-ras mutations.

Original languageEnglish
Pages (from-to)271-281
Number of pages11
JournalExperimental Lung Research
Volume31
Issue number2
DOIs
Publication statusPublished - Mar 2005

Fingerprint

Smoke
Tobacco Products
Tumors
Lung
Mutation
Neoplasms
Tobacco
Air
Codon
ras Genes
Environmental Exposure
Transgenic Mice
Animals
Recovery
Germ-Line Mutation
Incidence
Transgenes
Oncogenes
Gene expression
Sequence Analysis

Keywords

  • K-ras mutation
  • Lung tumorigenesis
  • p53 transgenic mice
  • Tobacco-smoke

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

K-ras mutations in lung tumors from p53 mutant mice exposed to cigarette smoke. / Yao, Ruisheng; Wang, Yian; D'Agostini, Francesco; Izzotti, Alberto; Lubet, Ronald A.; You, Ming; De Flora, Silvio.

In: Experimental Lung Research, Vol. 31, No. 2, 03.2005, p. 271-281.

Research output: Contribution to journalArticle

Yao, R, Wang, Y, D'Agostini, F, Izzotti, A, Lubet, RA, You, M & De Flora, S 2005, 'K-ras mutations in lung tumors from p53 mutant mice exposed to cigarette smoke', Experimental Lung Research, vol. 31, no. 2, pp. 271-281. https://doi.org/10.1080/0190214059090386
Yao, Ruisheng ; Wang, Yian ; D'Agostini, Francesco ; Izzotti, Alberto ; Lubet, Ronald A. ; You, Ming ; De Flora, Silvio. / K-ras mutations in lung tumors from p53 mutant mice exposed to cigarette smoke. In: Experimental Lung Research. 2005 ; Vol. 31, No. 2. pp. 271-281.
@article{91c7b7ed01124cd5be69931e881824ef,
title = "K-ras mutations in lung tumors from p53 mutant mice exposed to cigarette smoke",
abstract = "In this study, we used p53 trangenic mice to investigate whether mice carrying this germline mutation would be susceptible to tobacco smoke-induced lung tumorigenesis. We subjected male transgenic mice and their wild-type littermates to whole-body exposure to environmental cigarette smoke (ECS) for up to 9.5 months. K-ras gene expression was significantly increased, 28 days after ECS exposure, in the apparently healthy lung of p53 mutant mice. An increase of lung tumor incidence and multiplicity was observed in p53 transgenic mice after exposure to ECS for either 5 months, followed by recovery in air for 4.5 months, or 9.5 continuative months of exposure. Conversely, no tumorigenic effect was observed in their wild-type littermates. Sequence analysis of the K-ras gene indicated that mutations had occurred at codon 12, 13 or codon 61 in tumors both from the air control group and tobacco smoke treatment groups. K-ras mutations were found in 100{\%}, 100{\%} and 77{\%} of tumors from animals exposed to air, ECS for 5 months, followed by recovery in air for 4.5 months, and ECS for 9.5 continuative months, respectively. The K-ras mutations were seemingly not related to the p53 genotype of the animals or to ECS exposure. The mutation spectrum was similar in tumors from the different groups. An apparently higher incidence of K-ras codon 12 mutations in the 9.5-months ECS group was not statistically significant. These findings provide evidence that mice carrying a mutant p53 transgene appear to be more sensitive to ECS-induced lung tumors than the corresponding wild-type littermates. K-ras mutations seem to be independent of the p53 status but the early overexpression of this oncogene is related to the p53 status in ECS-exposed mice. These results suggest that tobacco smoke enhances lung tumorigensis primarily through promoting spontaneously occuring K-ras mutations.",
keywords = "K-ras mutation, Lung tumorigenesis, p53 transgenic mice, Tobacco-smoke",
author = "Ruisheng Yao and Yian Wang and Francesco D'Agostini and Alberto Izzotti and Lubet, {Ronald A.} and Ming You and {De Flora}, Silvio",
year = "2005",
month = "3",
doi = "10.1080/0190214059090386",
language = "English",
volume = "31",
pages = "271--281",
journal = "Experimental Lung Research",
issn = "0190-2148",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - K-ras mutations in lung tumors from p53 mutant mice exposed to cigarette smoke

AU - Yao, Ruisheng

AU - Wang, Yian

AU - D'Agostini, Francesco

AU - Izzotti, Alberto

AU - Lubet, Ronald A.

AU - You, Ming

AU - De Flora, Silvio

PY - 2005/3

Y1 - 2005/3

N2 - In this study, we used p53 trangenic mice to investigate whether mice carrying this germline mutation would be susceptible to tobacco smoke-induced lung tumorigenesis. We subjected male transgenic mice and their wild-type littermates to whole-body exposure to environmental cigarette smoke (ECS) for up to 9.5 months. K-ras gene expression was significantly increased, 28 days after ECS exposure, in the apparently healthy lung of p53 mutant mice. An increase of lung tumor incidence and multiplicity was observed in p53 transgenic mice after exposure to ECS for either 5 months, followed by recovery in air for 4.5 months, or 9.5 continuative months of exposure. Conversely, no tumorigenic effect was observed in their wild-type littermates. Sequence analysis of the K-ras gene indicated that mutations had occurred at codon 12, 13 or codon 61 in tumors both from the air control group and tobacco smoke treatment groups. K-ras mutations were found in 100%, 100% and 77% of tumors from animals exposed to air, ECS for 5 months, followed by recovery in air for 4.5 months, and ECS for 9.5 continuative months, respectively. The K-ras mutations were seemingly not related to the p53 genotype of the animals or to ECS exposure. The mutation spectrum was similar in tumors from the different groups. An apparently higher incidence of K-ras codon 12 mutations in the 9.5-months ECS group was not statistically significant. These findings provide evidence that mice carrying a mutant p53 transgene appear to be more sensitive to ECS-induced lung tumors than the corresponding wild-type littermates. K-ras mutations seem to be independent of the p53 status but the early overexpression of this oncogene is related to the p53 status in ECS-exposed mice. These results suggest that tobacco smoke enhances lung tumorigensis primarily through promoting spontaneously occuring K-ras mutations.

AB - In this study, we used p53 trangenic mice to investigate whether mice carrying this germline mutation would be susceptible to tobacco smoke-induced lung tumorigenesis. We subjected male transgenic mice and their wild-type littermates to whole-body exposure to environmental cigarette smoke (ECS) for up to 9.5 months. K-ras gene expression was significantly increased, 28 days after ECS exposure, in the apparently healthy lung of p53 mutant mice. An increase of lung tumor incidence and multiplicity was observed in p53 transgenic mice after exposure to ECS for either 5 months, followed by recovery in air for 4.5 months, or 9.5 continuative months of exposure. Conversely, no tumorigenic effect was observed in their wild-type littermates. Sequence analysis of the K-ras gene indicated that mutations had occurred at codon 12, 13 or codon 61 in tumors both from the air control group and tobacco smoke treatment groups. K-ras mutations were found in 100%, 100% and 77% of tumors from animals exposed to air, ECS for 5 months, followed by recovery in air for 4.5 months, and ECS for 9.5 continuative months, respectively. The K-ras mutations were seemingly not related to the p53 genotype of the animals or to ECS exposure. The mutation spectrum was similar in tumors from the different groups. An apparently higher incidence of K-ras codon 12 mutations in the 9.5-months ECS group was not statistically significant. These findings provide evidence that mice carrying a mutant p53 transgene appear to be more sensitive to ECS-induced lung tumors than the corresponding wild-type littermates. K-ras mutations seem to be independent of the p53 status but the early overexpression of this oncogene is related to the p53 status in ECS-exposed mice. These results suggest that tobacco smoke enhances lung tumorigensis primarily through promoting spontaneously occuring K-ras mutations.

KW - K-ras mutation

KW - Lung tumorigenesis

KW - p53 transgenic mice

KW - Tobacco-smoke

UR - http://www.scopus.com/inward/record.url?scp=14644435150&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=14644435150&partnerID=8YFLogxK

U2 - 10.1080/0190214059090386

DO - 10.1080/0190214059090386

M3 - Article

C2 - 15824025

AN - SCOPUS:14644435150

VL - 31

SP - 271

EP - 281

JO - Experimental Lung Research

JF - Experimental Lung Research

SN - 0190-2148

IS - 2

ER -